Merit Medical Systems Gross Profit 2012-2026 | MMSI
Merit Medical Systems annual/quarterly gross profit history and growth rate from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Merit Medical Systems gross profit for the quarter ending June 30, 2026 was $0.215B, a 16.63% increase year-over-year.
- Merit Medical Systems gross profit for the twelve months ending June 30, 2026 was $0.782B, a 13.78% increase year-over-year.
- Merit Medical Systems annual gross profit for 2025 was $0.738B, a 14.76% increase from 2024.
- Merit Medical Systems annual gross profit for 2024 was $0.643B, a 10.18% increase from 2023.
- Merit Medical Systems annual gross profit for 2023 was $0.584B, a 12.48% increase from 2022.
|
Merit Medical Systems Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $738 |
| 2024 | $643 |
| 2023 | $584 |
| 2022 | $519 |
| 2021 | $485 |
| 2020 | $401 |
| 2019 | $432 |
| 2018 | $395 |
| 2017 | $326 |
| 2016 | $265 |
| 2015 | $236 |
| 2014 | $225 |
| 2013 | $194 |
| 2012 | $182 |
| 2011 | $165 |
|
Merit Medical Systems Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-06-30 | $215 |
| 2026-03-31 | $185 |
| 2025-12-31 | $195 |
| 2025-09-30 | $186 |
| 2025-06-30 | $184 |
| 2025-03-31 | $172 |
| 2024-12-31 | $173 |
| 2024-09-30 | $158 |
| 2024-06-30 | $161 |
| 2024-03-31 | $152 |
| 2023-12-31 | $151 |
| 2023-09-30 | $142 |
| 2023-06-30 | $153 |
| 2023-03-31 | $138 |
| 2022-12-31 | $135 |
| 2022-09-30 | $129 |
| 2022-06-30 | $135 |
| 2022-03-31 | $121 |
| 2021-12-31 | $129 |
| 2021-09-30 | $120 |
| 2021-06-30 | $124 |
| 2021-03-31 | $112 |
| 2020-12-31 | $111 |
| 2020-09-30 | $102 |
| 2020-06-30 | $84 |
| 2020-03-31 | $104 |
| 2019-12-31 | $112 |
| 2019-09-30 | $104 |
| 2019-06-30 | $112 |
| 2019-03-31 | $105 |
| 2018-12-31 | $105 |
| 2018-09-30 | $102 |
| 2018-06-30 | $100 |
| 2018-03-31 | $88 |
| 2017-12-31 | $86 |
| 2017-09-30 | $81 |
| 2017-06-30 | $84 |
| 2017-03-31 | $76 |
| 2016-12-31 | $70 |
| 2016-09-30 | $68 |
| 2016-06-30 | $67 |
| 2016-03-31 | $60 |
| 2015-12-31 | $60 |
| 2015-09-30 | $59 |
| 2015-06-30 | $61 |
| 2015-03-31 | $55 |
| 2014-12-31 | $60 |
| 2014-09-30 | $57 |
| 2014-06-30 | $56 |
| 2014-03-31 | $52 |
| 2013-12-31 | $53 |
| 2013-09-30 | $51 |
| 2013-06-30 | $47 |
| 2013-03-31 | $43 |
| 2012-12-31 | $45 |
| 2012-09-30 | $45 |
| 2012-06-30 | $47 |
| 2012-03-31 | $44 |
| 2011-12-31 | $42 |
| 2011-09-30 | $41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $5.143B | $1.516B |
| Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $103.449B | 21.74 |
| Cardinal Health (CAH) | United States | $54.083B | 20.65 |
| Becton Dickinson (BDX) | United States | $50.107B | 13.99 |
| West Pharmaceutical Services (WST) | United States | $25.477B | 42.59 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.194B | 0.00 |
| Align Technology (ALGN) | United States | $10.775B | 16.66 |
| Cooper (COO) | United States | $10.384B | 11.85 |
| Henry Schein (HSIC) | United States | $9.670B | 16.34 |
| DENTSPLY SIRONA (XRAY) | United States | $2.021B | 7.09 |
| CONMED (CNMD) | United States | $1.409B | 9.84 |
| STAAR Surgical (STAA) | United States | $1.124B | 35.02 |
| Pro-Dex (PDEX) | United States | $0.230B | 21.45 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |